Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says

Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says

Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.

Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.
Lire l’article complet sur le site source
Bloomberg — Markets (EN)




Besoin d'un service ? Discutez maintenant !
🤖

Assistant eFastWork

En ligne

📩 Envoyer un message à notre équipe


ou envoyez un message vocal
👋

Bienvenue !

Entrez votre email pour commencer à chatter.

Email utilisé uniquement pour vous répondre.